- Home
- BCG vs CCM Comparison
BCG vs CCM Comparison
Compare BCG & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCG | CCM |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6M | 21.3M |
| IPO Year | 2025 | 2009 |
Fundamental Metrics
Financial Performance| Metric | BCG | CCM |
|---|---|---|
| Price | $1.07 | $3.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 16.2K | 11.8K |
| Earning Date | 11-12-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.50 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $187,144,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.50 | ★ N/A |
| Revenue Growth | ★ 10.80 | N/A |
| 52 Week Low | $0.95 | $2.79 |
| 52 Week High | $3.44 | $6.80 |
Technical Indicators
Market Signals| Indicator | BCG | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 49.99 |
| Support Level | $0.95 | $2.98 |
| Resistance Level | $1.67 | $4.28 |
| Average True Range (ATR) | 0.04 | 0.53 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 75.06 | 53.95 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.